Immune Response

Chinese scientists have developed an inhalable COVID-19 vaccine that promises "effective protection" against the virus.

A study from Cambridge University found that almost 25% of those who received the COVID-19 mRNA vaccines have developed unintentional proteins.

A study by researchers from the United Kingdom's National Health Service found that COVID-19 vaccines "may trigger" rheumatic inflammatory diseases.

Pharmaceutical giant says its vaccine only "may be" effective in reducing "severe disease and hospitalization," and falls short of confirming protection from infection.

Data taken from the U.S. Centers for Disease Control and Prevention (CDC) confirms that 35,980 deaths have been linked to the COVID vaccine; medical literature confirms vaccine-linked disease to autism.

"You clearly don't understand the pathway, do you? Because you can't explain it," Sen. Rennick said.

Vaccinated patient had "no medical history of diabetes."

Research shows that "the duration of protection after breakthrough infection was longer than after the third/booster vaccination."

However, a recent U.K. community-based population study found that those who have previously been infected with SARS-CoV-2, which causes COVID-19, demonstrate a lower rate of new Omicron BA.4/BA.5 infections compared to those who were vaccinated.

A case report in the medical journal Frontiers in Immunology highlights a rare case of a patient developing rheumatoid encephalitis after receiving a booster immunization of the mRNA-1273 COVID-19 vaccine, raising concerns about potential adverse reactions to the vaccine.